Companies that raised concerns in October last year were told the catch-up reductions reflected changes originally made in 2015 that enabled statutory reductions on 'brands' of PBS-listed medicines.
The current issue with 'catch-ups' was raised last year but dismissed
July 28, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
Wegovy pill available in Australia from today by private prescription
November 20, 2026 - - Latest News -
It happened last time, so it makes sense to start next week assuming it as the base case
November 20, 2026 - - Latest News -
Applying the principles of the Reserve Bank review to HTA advisory committees
November 20, 2026 - - Latest News -
Government turns again to cheaper medicines as Guild eyes co-payment freeze
November 19, 2026 - - Latest News -
Moderna's mRNA flu vaccines and a GLP-1 review headline March PBAC agenda
November 19, 2026 - - Latest News -
New Zealand risks losing $763 million clinical trials sector as other countries step up
November 19, 2026 - -
A tale of two government programs - one held flat and the other still running hot
November 19, 2026 - - Latest News

